$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Crizotinib price and reference after medical insurance reimbursement in 2026
2026-02-01 22:25:32
Check Details
Mechanism and pharmacological analysis of aprocitentan in the treatment of pulmonary arterial hypertension
2026-02-01 22:25:32
Check Details
Clinical application effect of tilpotide/tilsiparatide (Mufenda) in the treatment of diabetes
2026-02-01 22:25:32
Check Details
Comprehensive explanation of the mechanism of action and clinical efficacy of Pitobrutinib/Pitobrutinib (Zepali)
2026-02-01 22:25:32
Check Details
Safety analysis of combined use of talazoparib (Tazena) and enzalutamide
2026-02-01 22:25:32
Check Details
Analysis of whether crizotinib (Xalkori) is the last line of treatment for patients
2026-02-01 22:25:32
Check Details
Detailed analysis and explanation of pharmacological effects, indications and clinical application value of Omarigliptin tablets
2026-02-01 22:25:32
Check Details
Where can I buy lecanemab-LEQEMBI in the country?
2026-02-01 22:25:32
Check Details
What is golodirsen and analysis of its pharmacological effects
2026-02-01 22:25:32
Check Details
Disitamab drug purchase reference and cost explanation
2026-02-01 22:25:32
Check Details
Isatuximab (Isatuximab) manufacturer information and purchase price
2026-02-01 22:25:32
Check Details
Analysis of common clinical adverse reactions and safe medication tips of capicitinib tablets
2026-02-01 22:25:32
Check Details
1
2
...
2361
2362
2363
2364
2365
2366
2367
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
2
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
3
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
4
ROS and Cancer: The Potential of Natural Antioxidants
5
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
6
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
7
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
8
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
9
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
10
From Causes to Treatments—Exploring Medical Breakthroughs
11
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
12
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship